Zosano Announces FDA Submission of New Drug Application for Qtrypta
23 déc. 2019 08h00 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the submission of a 505(b)(2) New Drug...
Zosano Announces Pricing of Registered Direct Offering
27 nov. 2019 09h29 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has entered into a securities purchase...
Zosano Pharma Reports Third Quarter 2019 Financial Results and Provides Corporate Update
14 nov. 2019 16h05 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended...
Zosano Pharma Announces Completion of Pre-NDA Meetings with FDA for Qtrypta™
13 nov. 2019 16h30 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has received minutes from pre- New...
Zosano Pharma to Host Conference Call on Third Quarter 2019 Financial Results and Provide Operational Update
07 nov. 2019 09h00 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and...
Zosano Pharma Initiates Phase 2/3 Clinical Study in Cluster Headache
24 oct. 2019 09h00 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has begun enrolling cluster...
Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23 oct. 2019 16h05 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the Board of Directors granted a stock...
Zosano Pharma Announces CEO Transition
08 oct. 2019 09h00 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that Steven Lo, veteran biotechnology and...
Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27 sept. 2019 16h05 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the Board of Directors granted a stock...
Zosano Pharma to Present at the Cantor Global Healthcare Conference
26 sept. 2019 09h00 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its chairman, president and chief...